Why VitaSmart’s FDA nod could shift transplant strategies for extended-criteria grafts
Find out how Bridge to Life’s FDA-cleared VitaSmart system could reshape liver transplant workflows in 2026.
Find out how Bridge to Life’s FDA-cleared VitaSmart system could reshape liver transplant workflows in 2026.